意大利医疗中心调查显示771名医护人员 Long COVID 12个月患病情况
Long COVID burden in healthcare workers: a 12-month survey of 771 cases
一项针对意大利 IRCCS Policlinico San Matteo 医院医护人员的匿名调查发现,在771例有SARS-CoV-2感染记录的病例中,存在长期新冠综合征。该调查于2025年3月至5月进行,随访期至少3个月,旨在提供12个月以上的长期流行病学数据。研究定义了长期新冠为感染后3、6或12个月仍存在持续症状,并分析了不同职业角色的风险差异。
Introduction
The COVID-19 pandemic has fundamentally altered our understanding of viral infections and their long-term consequences. While most individuals recover from acute SARS-CoV-2 infection within 2–4 weeks, a substantial subset experiences persistent symptoms collectively termed Long COVID syndrome. The National Institute for Health and Care Excellence (NICE) defines this condition as signs and symptoms persisting beyond 4 weeks from acute infection, with post-COVID-19 syndrome specifically referring to symptoms lasting 12 weeks or more1. The WHO defines Post COVID-19 condition (PCC) as the onset of symptoms within 3 months of a SARS-CoV-2 infection, with these symptoms lasting for at least 2 months; such symptoms cannot be explained by alternative causes diagnosis2.
Healthcare workers represent a unique population for Long COVID syndrome research due to their elevated exposure risk and critical role in healthcare delivery. Al-Oraibi et al. (2023) emphasized that healthcare workers provide a dual perspective as both caregivers and patients, offering unique insights into living with Long COVID syndrome that are valuable to research3. Recent evidence from the UK demonstrates that healthcare workers face particular challenges with Long COVID syndrome, often managing complex and dynamic symptoms while continuing to work4.
Current evidence on Long COVID syndrome among healthcare workers remains limited and inconsistent. While several studies have documented elevated infection rates among healthcare workers5,6,7,8,9, data on Long COVID prevalence in this population are sparse and vary widely (ranging from 15.0% to 45.0%) depending on definitions, follow-up duration, and healthcare settings10,11. Most existing studies are limited by small sample sizes, short follow-up periods (typically ≤ 6 months), or lack of temporal assessment of symptom evolution. Furthermore, few studies have examined occupational variation in Long COVID risk beyond the simple dichotomy of clinical versus non-clinical roles, leaving questions about differential vulnerability across specific healthcare professions unanswered.
There is a critical need for larger-scale studies with extended follow-up (≥ 12 months) that systematically assess Long COVID symptom evolution over time and examine variation across diverse healthcare occupational categories. Such data are essential to inform evidence-based occupational health policies and resource allocation in healthcare institutions.
Understanding the prevalence and characteristics of Long COVID syndrome in healthcare workers is essential to inform occupational health policies, workforce planning, and support services12,13,14.
This survey aims to provide comprehensive epidemiological data on Long COVID syndrome prevalence among healthcare workers at a major Italian medical center.
Methods
This survey was conducted among employees of IRCCS Policlinico San Matteo Foundation who had documented SARS-CoV-2 infection since February 2020 and December 2024. The survey was administered between March 28 and May 15, 2025, allowing for a minimum follow-up period of 3 months for all participants (maximum follow-up: 4 years for early pandemic cases). The survey was approved by the Comitato Etico Territoriale Lombardia 6 (Territorial Ethics Committee Lombardia 6), Fondazione IRCCS Policlinico San Matteo, Pavia, Italy and conducted according to the Declaration of Helsinki principles (Protocol number G1.2024.0006726, 26/02/2024)15. Because the survey was completely anonymous and did not allow any identification of the participants, the Comitato Etico Territoriale Lombardia 6 waived the requirement for written informed consent; participation was entirely voluntary, and completion and submission of the anonymous questionnaire were taken as implied consent to participate.
An anonymous online questionnaire was distributed via institutional intranet to all employees from a total of 1,862 healthcare workers using the institutional REDCap survey instrument. The survey collected information on demographics, occupational roles, medical history, acute COVID-19 symptoms and persistent symptoms at 3, 6, and 12 months post-infection.
Long COVID syndrome was defined as the presence of any persistent symptoms at 3, 6, or 12 months following acute SARS-CoV-2 infection, consistent with WHO and NICE definitions1,2. Healthcare workers were categorized by specific job positions including nurses, physicians/surgeons, administrative staff, technical staff, biologists, research staff, pharmacists, and others.
Demographic and occupational variables were selected based on prior evidence of association with Long COVID risk and data availability within our institutional framework. Age categories were chosen to reflect typical career stages in healthcare professions. Job position was categorized to capture both clinical exposure patterns and occupational stress profiles. Pre-existing comorbidities were included given their established association with Long COVID risk in the general population16,17.
Several potentially relevant factors were not assessed in our survey: - Vaccination status: Data collection occurred in 2025, by which time nearly all healthcare workers had received multiple vaccine doses, limiting meaningful stratification - Education level and income: These variables are highly collinear with job position in healthcare settings and would not provide additional discriminatory power - COVID-19 severity during acute infection: This information was not systematically recorded in occupational health records for all participants - Specific workplace characteristics: Environmental factors (ventilation, office vs. ward) were not systematically documented.
Statistical analysis
All analyses were performed using Stata software (release 19.5, StataCorp, College Station, TX, USA) and R (version 4.4.2, R Core Team 2024); a 2-sided p-value < 0.05 was considered statistically significant. Continuous data are summarized with the mean and interquartile range (IQR) while categorical variables are presented as counts and percentages. Prevalence of Long COVID syndrome is presented together with their exact binomial 95% confidence intervals. It was compared between groups, defined by either age categories, gender or job position, as well as pre-existing comorbidities, with the Fisher exact test. Changes over time were assessed using the McNemar test. Multiple correspondence analysis was used to elicit any distinct association among symptoms. Unsupervised learning techniques were assessed, and Uniform Manifold Approximation and Projection (UMAP) and Density-Based Spatial Clustering of Applications with Noise (DBSCAN) were chosen as the most effective approaches for identifying patient aggregation. In a sensitivity analysis the prevalence of long COVID was re-estimated while assuming all missing responders were free of long COVID. To address potential non-response bias, we performed a sensitivity analysis assuming that all non-respondents (n = 1,091; 58.59% of eligible workers) were asymptomatic and did not experience Long COVID syndrome. This represents a ‘worst-case scenario’ for prevalence estimation. Under this assumption, the denominator for prevalence calculation becomes the total number of employees with documented SARS-CoV-2 infection (n = 1,862) rather than only survey respondents (n = 771), yielding a lower bound estimate for Long COVID prevalence.
Results
Participant characteristics and prevalence of long COVID
A total of 771 healthcare workers participated in this study, out of 1,862 previously positive for SARS-CoV-2 infection, representing a response rate of 41.41% (95% CI 39.2–43.7%). Age distribution favored the 41–50 (24.0%) and 51–60 years (38.0%) categories (Table 1), with 77.0% of the workforce being women. About half of them did bedside work. Physicians represented 18.0% of the cohort, while the majority (30.0%) were nurses or administrative staff (23.0%). 9% of the cohort had multiple comorbidities.
The overall Long COVID syndrome prevalence was 27.9% (215/771; 95% CI: 24.7–31.2%). In a sensitivity analysis assuming non-responders to the survey as free of Long COVID, the prevalence reduced to 11.5% (95% CI 10.1–13.1%). As shown in Table 1, the prevalence of Long COVID syndrome showed some heterogeneity across age categories, with the highest prevalence between 41 and 60 years, though without statistical significance (p = 0.116). Conversely, there was a significant association between job position and Long COVID syndrome (p = 0.004), with the highest prevalence in nurses (35.0%) and other health professionals (38.0%), but also among the administrative staff (32.0%). Finally, subjects who had multiple preexisting comorbidities (from 2 to 5) had a two-fold higher prevalence of Long COVID syndrome (49.0% vs. 24.0%, p < 0.001). Hypertension (52.0%), rheumatologic disorders (25.0%), migraine (28.0%) and obesity (16.0%) were the most frequent associated comorbidities.
The prevalence of Long COVID syndrome declined considerably over time, from 26.0% (95% CI: 23.0–29.0%) at three months to 16.0% (95% CI: 14.0–19.0%) at one year. (Table 2). The association with job position and preexisting multiple comorbidities was present at each time point. In addition, Long COVID syndrome was more persistent over time in the middle-age categories, while it declined markedly in the youngest ages (from 20.0% to 14.0% and 6.0%) but also in the oldest ages (from 23.0% to 20.0% and 14.0%) both at 6 and 12 months (p = 0.097 and p = 0.011, respectively, Table 2).
Symptoms evolution over time
The median number of symptoms per subject was 3 at 3 months after a SARS-Cov-2 infection; it decreased to 2 at 6 and 12 months (Table 3). At 3 months, the most common symptoms were fatigue (14.3%), joint and muscle pain (11.9%), and concentration and memory issues (9.6% and 8.4%). The same four symptoms also ranked highest at both 6 and 12 months, although their prevalence gradually decreased (Table 3). Dyspnea, reported in 4.5% of patients at 3 months, nearly disappeared by 12 months (1.4%), along with dysgeusia, dysosmia, and sleep disorders, which saw their prevalence halve or more by that time.
To potentially elicit aggregation of symptoms that could identify different syndromes we performed multiple correspondence analysis. As shown in Fig. 1, at neither of the time points symptoms appeared to aggregate in separate distributions patterns. However, when applying DBSCAN clustering to a UMAP-reduced patient-reported symptoms at 3 months, we identified three distinct and well-separated patient groups (Fig. 2) with varying symptom burdens.
Multiple corresponding analysis for displaying the aggregation of symptoms at 3, 6 and 12 months.
DBSCAN clustering on UMAP-reduced patient-reported symptoms at 3 months.
Cluster I (n = 36) showed minimal symptoms, with low rates of respiratory and cognitive disorders (Supplementary Table 1); Cluster II (n = 95) had a moderate symptom burden, marked by increased dyspnea, cough, fatigue, and musculoskeletal pain. Cluster III (n = 69) exhibited the highest symptom burden, especially neurocognitive impairments such as concentration and memory difficulties, alongside fatigue, joint pain, and dysthymia. These clusters did not differ substantially by age, gender, or medical history. Notably, the distinct symptom patterns at 3 months tended to fade over time.
As shown in Table 4, the proportion of patients with new diagnoses is relatively low (from 6.8 to 4.7% at 3 and 12 months). Mostly, a single new diagnosis was made; in all cases with an incidence below 2.0%.
Discussion
In this survey among 771 healthcare workers, we show 27.9% (95% CI: 24.7–31.2%) of individuals with previous SARS-CoV-2 infection report symptoms related to Long COVID syndrome, presenting significant work-related and temporal variations that are of urgent importance for healthcare workforce planning. he 27.9% of our healthcare workers with Long COVID syndrome is at the upper end of reported prevalence across general population studies, which range widely from 10.0% to 50.0% depending on study methodology and definitions5,6,7. In particular, our results are consistent with recent systematic reviews quoting the prevalence rates of Long COVID syndrome among healthcare workers between 25.0 and 35.0%8,9. The higher prevalence compared to some general population studies may be attributable to the greater exposure risk and job-related stressors in healthcare settings. Significantly, our prevalence compares to 30.0% found by Mutambudzi et al. (2021) among UK healthcare workers6, but lower than the 19.0% recorded in a Norwegian healthcare worker cohort10. This discrepancy may result from variations in health system burden, patient population demographics, or specific pandemic strategies. The decline in our survey from 26.0% at 3 months post-infection to 16.0% at 12 months aligns with the temporal recovery observed in the longitudinal studies by Taquet et al. (2021) and Sudre et al. (2021)11,18, and may suggest the expected patterns of symptom persistence, regardless of population characteristics. Job position and Long COVID syndrome prevalence were among the most important predictors (p = 0.004), a new result having critical implications for occupational health policies. Nurses were the professional group with highest risk (35.0%), then other health professionals (38.0%) and administrative staff (32.0%), and the lowest prevalence was observed in research staff (8.0%). This occupational gradient is larger than observed in earlier studies that concentrated on infection risk, rather than the issue of developing Long COVID syndrome.
The increased risk in nurses is of particular concern, as they are at the frontline for delivery of health care, and is consistent with recent findings from Torrance et al. (2024) who reported on the double duty of being a carer and having to cope with Long COVID syndrome4. The high response rate among administrative workers (32.0%) challenges the common belief that only activities involving direct patient contact carry a significant risk, suggesting that other perceived workplace factors such as stress, workload, or employer support may also be influential. Remarkably, we show here that demographic characteristics (age p = 0.116, sex p = 0.330) were not significantly associated with Long COVID syndrome prevalence, which is not in accordance with general population studies showing a consistent increase in prevalence in women and middle-aged people19,20.
This may indicate that workplace exposures and conditions of stress have more influence over risk than do expected demographic profiles in this occupational setting.
A particularly striking and unexpected finding of our study is the nearly equivalent Long COVID prevalence between administrative staff (32.0%) and nurses (35.0%), which challenges conventional assumptions about occupational risk being primarily determined by direct patient contact. Several non-mutually exclusive mechanisms may explain this observation. Administrative staff typically work in enclosed office environments with potentially suboptimal ventilation compared with clinical areas, where air-exchange standards are higher; during peak pandemic periods, shared offices, meeting rooms and common areas may have facilitated aerosol transmission to a degree comparable with that experienced by clinical personnel. In parallel, the pandemic placed extraordinary demands on healthcare administration—including emergency response coordination, staff scheduling during shortages and management of rapidly changing protocols—and chronic occupational stress is increasingly recognised as a potential risk factor for Long COVID syndrome21,22, possibly through immune dysregulation or allostatic load mechanisms. Differential exposure to SARS-CoV-2 variants of varying pathogenicity could also have contributed, although our data do not allow examination of infection timing by job category. Sociodemographic confounding may further play a role, as administrative and nursing roles in our cohort share a marked female predominance and partly overlapping comorbidity profiles. Finally, differences in symptom awareness and reporting propensity between occupational groups cannot be excluded, although the direction of any such bias remains unclear.
This finding has important policy implications. It suggests that occupational health surveillance and Long COVID support services should not be restricted to frontline clinical personnel but should encompass all occupational categories in healthcare institutions. Furthermore, it highlights the need for comprehensive infection prevention measures throughout healthcare facilities, including administrative areas, and consideration of occupational stressors beyond direct patient care. Further research should specifically investigate: - Environmental factors (ventilation, office layout, crowding) in administrative versus clinical areas - Temporal patterns of infection and variant exposure by job category - Psychosocial stress measures and their association with Long COVID across occupational groups - Prospective cohort designs that can better disentangle these potential mechanisms.
The age-associated recovery trajectories seen in our survey shed light on the natural history of Long COVID. Although the overall prevalence decreased between 26.0% and 16.0% over 12 months, the younger individuals (aged 20–30) exhibited the greatest improvements (from 20.0% to 6.0%), while middle-aged workers (aged 51–60) had the highest persistence rate (from 31.0% to 23.0%). This aligns with most population studies, where older age is associated with worse outcomes23,24.
The better recovery in younger healthcare workers might suggest higher physical resilience, but may also reflect differences in symptom reporting or return-to-work pressures. The high prevalence of prolonged symptoms among middle-aged workmen is also consistent with the results of Logue et al. (2021) who reported a longer recovery in 40–60-year-olds25, yet our healthcare worker sample demonstrated a less pronounced age effect compared with that reported in community samples.
The symptom cluster of Long COVID syndrome in our cohort - fatigue (14.3% after 3 months), joint and muscle pain (11.9%), concentration difficulties (9.6%), and memory disturbances (8.4%) - is consistent with the symptom hierarchy reported in meta-analyses on Long COVID syndrome26,27. Nevertheless, our healthcare workers tended to report a slightly lower prevalence of individual symptoms than those for the general population studies, which may suggest different reporting thresholds and/or the “healthy worker effect”.
The persistence of neurocognitive symptoms is in stark contrast with the resolution of respiratory symptoms (dyspnea: 4.5% to 1.4%; cough: 3.5% to 1.0%), a primarily neurological and systemic disease21,28. This pattern has an immediate bearing for health care providers, whose cognitive functioning affects the quality of health care and patient safety.
Our clustering results identified three clusters at 3 months post infection, and the high-burden cluster (Cluster III, n = 69) showed frequent and significant neurocognitive deficits. This heterogeneity of phenotypes is consistent with emerging attempts to define subtypes of Long COVID syndrome29,30, but losing the salience of particular patterns over time also indicates that specific symptom clustering at symptom onset, while informative, may not necessarily be predictive of long-term outcomes.
A crude 2-fold higher prevalence of Long COVID syndrome in healthcare workers with multimorbidity (49.0% vs. 24.0%, p < 0.001) is one of the most robust predictive associations in our survey. The result further confirms the observation of elevated risk in the comorbid general population16,31 and has significance for health workforce planning.
The comorbidities specific to Long COVID syndrome in our cohort – hypertension (52.0%), rheumatologic conditions (25.0%), migraine (28.0%), and obesity (16.0%) – closely resemble risk factors identified in community-based research17,32. Nevertheless, the relationship between migraine and being a healthcare worker may be indicative of a high-stress healthcare work environment and deserves further investigation as a potentially modifiable exposure.
The relatively uncommon occurrence of new diagnoses (6.8% at 3 months, 4.7% at 12 months) further supports the increasing body of evidence that Long COVID syndrome is mainly functional rather than structural disease33,34. This has implications for diagnostics and resource allocation when the goal is to interrupt transmission, as extensive diagnostic investigations do not provide greater treatment benefits than symptomatic care.
Our results have critical implications for healthcare system surge capacity and resiliency in the current post-pandemic recovery period and for pandemic preparedness in the future. While over 25.0% of healthcare staff have Long COVID syndrome and nurses are at greatest risk, organizations need to invest in strategies to keep their workforces steady. The concentration of cases within direct-care workers is of special concern, because these positions are essential to the delivery of care and hard to fill.
The occupational risk stratification we identified—nurses 35.0% risk, administrative staff 32.0% risk, and research staff 8.0% risk—represents baseline data needed for planning the workforce and allocation resources during future health emergencies. Age-based recovery profiles imply that policies regarding return-to-work may need to be personalized; young workers can resume full responsibilities sooner, but older workers might need extended conditioning.
The 41.41% response rate creates the possibility of selection bias, given that symptomatic participants could be more likely to respond. Our sensitivity analysis involving asymptomatic non-responders would lower overall prevalence to 11.5% (95% CI 10.1–13.1%); the wide resulting range (11.5% to 27.9%) highlights significant uncertainty in the true prevalence of Long COVID. However, this scenario is an extreme assumption that is unlikely to apply in practice.
The substantial difference between our primary prevalence estimate (27.9%, 95% CI: 24.7–31.2%) and the sensitivity analysis result (11.5%, 95% CI: 10.1–13.1%) underscores the critical influence of non-response bias in cross-sectional surveys. This 2.4-fold difference represents a major source of uncertainty in estimating the true burden of Long COVID among healthcare workers.
Several considerations suggest that the true prevalence is likely to fall between these bounds rather than at either extreme. A complete absence of symptoms among all non-respondents is implausible, since symptomatic individuals may be either more motivated to report their experience or less likely to participate because of fatigue or time constraints. Our primary estimate is also broadly consistent with the existing literature on Long COVID in healthcare workers8,9, whereas the lower bound appears inconsistent with population-based studies; in addition, a 11.5% prevalence would imply an unusually high recovery rate compared with current Long COVID epidemiology. Taken together, these elements indicate that healthcare workforce planning should account for a potential Long COVID burden between 11.5% and 27.9%, that resource allocation for occupational health services requires conservative planning, and that future studies should adopt strategies to minimise non-response bias, such as repeated follow-up contacts, incentives and shorter survey instruments.
The true prevalence most likely approximates our primary estimate, but the uncertainty highlighted by this sensitivity analysis emphasizes the need for cautious interpretation and continued monitoring.
A limitation of our survey may be due to the dependence on self-reported symptoms without verification; however, this is consistent with the majority of Long COVID syndrome research, as the condition is primarily subjective. The 12-month follow-up, though long, may not be long enough to completely capture the natural history of Long COVID, as some studies indicate that symptoms may persist or transform for more than one year22,35.
Implications for healthcare institutions
Occupational health services must be equipped to provide long-term follow-up for a substantial proportion of post-COVID workers. Workplace accommodations and graduated return-to-work programs may be necessary for affected employees. Preventive strategies should extend beyond frontline clinical staff to include administrative and support personnel. Special attention should be directed toward workers with multiple comorbidities.
Survey limitations include retrospective symptom reporting, potential non-response bias (response rate 41.41%), and the absence of objective clinical measures. The sensitivity analysis suggests that the true prevalence could range from 11.5% to 27.9%, depending on symptom rates among non-respondents.
Conclusions
In this 12-month survey, more than one-quarter (27.9%) of healthcare workers with documented SARS-CoV-2 infection developed Long COVID syndrome, with point prevalence declining from 26.0% at three months to 16.0% at twelve months. Risk varied markedly by occupational role and was substantially higher in workers with multiple comorbidities, supporting targeted occupational health surveillance and graduated return-to-work strategies that extend beyond frontline clinical staff. Future research should employ prospective longitudinal designs with objective clinical assessments to better characterize occupational risk factors.
References
National Institute for Health and Care Excellence. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE Guideline [NG188]. (2021).
World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. (2021).
Al-Oraibi, A., Woolf, K., Fatimah, S. & Pareek, M. Healthcare workers must be included in Long COVID syndromeresearch in the UK. BMJ 382, p1721 (2023).
Torrance, N. et al. Lived experience of work and Long COVID syndrome in healthcare staff. Occup. Med. (Lond). 74 (2), 78–85 (2024).
Chen, C. et al. Global prevalence of post-acute sequelae of COVID-19 (PASC) or long COVID: a meta-analysis and systematic review. Ann. Intern. Med. 175 (10), 1395–1406 (2022).
Mutambudzi, M. et al. Occupation and risk of severe COVID-19: prospective cohort study of 120,075 UK Biobank participants. Occup. Environ. Med. 78 (5), 307–314 (2021).
Arjun, M. C. et al. Long COVID syndrome following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J. Clin. Invest. 133 (1), e162115 (2023).
Gholami, M. et al. COVID-19 and healthcare workers: a systematic review and meta-analysis. Int. J. Infect. Dis. 104, 335–346 (2021).
Magnavita, N., Tripepi, G. & Di Prinzio, R. R. Symptoms in health care workers during the COVID-19 epidemic. A cross-sectional survey. Int. J. Environ. Res. Public. Health. 17 (14), 5218 (2020).
Bråten, L. C. et al. Long COVID syndrome in healthcare workers: a cohort study of prevalence, symptom burden, and clinical outcomes 18 months post-infection. J. Occup. Environ. Med. 65 (2), e84–e90 (2023).
Taquet, M. et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study. Lancet Public. Health. 6 (9), e575–e582 (2021).
Sisó-Almirall, A. et al. Long Covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int. J. Environ. Res. Public. Health. 18 (8), 4350 (2021).
Michelen, M. et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 6 (9), e005427 (2021).
Yong, S. J. Long COVID syndrome or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. Lond. Engl. 53 (10), 737–754 (2021).
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310 (20), 2191–2194 (2013).
Tsampasian, V. et al. Risk factors associated with post-COVID-19 condition: a systematic review and meta-analysis. JAMA Intern. Med. 183 (6), 566–580 (2023).
Zeng, N. et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic in the general population. Commun. Med. (Lond). 3 (1), 100 (2023).
Sudre, C. H. et al. Attributes and predictors of long COVID. Nat. Med. 27 (4), 626–631 (2021).
Nguyen, L. H. et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public. Health. 5 (9), e475–e483 (2020).
Subramanian, A. et al. Symptoms and risk factors for Long COVID syndrome in non-hospitalized adults. Nat. Med. 28 (8), 1706–1714 (2022).
Dubey, S. et al. Psychosocial impact of COVID-19. Diabetes Metab. Syndr. 14 (5), 779–788 (2020).
Tran, V. T., Porcher, R., Pane, I. & Ravaud, P. Course of post COVID-19 disease symptoms over time in the ComPaRe Long COVID syndrome prospective e-cohort. Nat. Commun. 13 (1), 1946 (2022).
Huang, C. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397 (10270), 220–232 (2021).
Morin, L. et al. Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA 325 (15), 1525–1534 (2021).
Logue, J. K. et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 4 (2), e210830 (2021).
Ceban, F. et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 101, 93–135 (2022).
Groff, D. et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 4 (10), e2128568 (2021).
Premraj, L. et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J. Neurol. Sci. 434, 120162 (2022).
Kenny, G. et al. Identification of Distinct Long COVID syndrome Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms. Open. Forum Infect. Dis. 9 (4), ofac060 (2022).
Whitaker, M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people. Nat. Commun. 13 (1), 1957 (2022).
Ballering, A. V., van Zon, S. K. R., Olde Hartman, T. C. & Rosmalen, J. G. M. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400 (10350), 452–461 (2022).
Yomogida, K. et al. Post-COVID conditions among adult COVID-19 survivors aged 18–64 and ≥ 65 years - United States, March 2020-November 2021. MMWR Morb Mortal. Wkly. Rep. 71 (21), 713–717 (2022).
Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med. 27 (4), 601–615 (2021).
Soriano, J. B., Murthy, S., Marshall, J. C., Relan, P. & Diaz, J. V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22 (4), e102–e107 (2022).
Davis, H. E. et al. Characterizing Long COVID syndrome in an international cohort: 7 months of symptoms and their impact. E Clin. Med. 38, 101019 (2021).
来源:Nature 健康护理主题 · nature.com